Flaxseed enhances the beneficial effect of low-dose estrogen therapy at reducing bone turnover and preserving bone microarchitecture in ovariectomized rats.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

• Publication date

  2014-01-16

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1139/apnm-2013-0417PMID 24844286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Docosahexaenoic Acid

  2016cited by this paper
• An 8-O-4' norlignan exerts oestrogen-like actions in osteoblastic cells via rapid nongenomic ER signaling pathway.

  2015cited by this paper
• The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis

  2013cited by this paper
• Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk

  2013cited by this paper
• Flaxseed and Bone Health in Animal Models of Menopause

  2013cited by this paper
• Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study.

  2013cited by this paper
• Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.

  2011cited by this paper
• Manipulation of flaxseed inhibits tumor necrosis factor-alpha and interleukin-6 production in ovarian-induced osteoporosis.

  2011cited by this paper
• Consumption of different sources of omega-3 polyunsaturated fatty acids by growing female rats affects long bone mass and microarchitecture.

  2011cited by this paper
• Comparison of active vitamin D compounds and a calcimimetic in mineral homeostasis.

  2010cited by this paper
• Effects of dietary supplementation of

  2010cited by this paper
• Revisiting Estrogen: Efficacy and Safety for Postmenopausal Bone Health

  2010cited by this paper
• Endogenous n‐3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis

  2009cited by this paper
• Meta-analysis of the effects of flaxseed interventions on blood lipids.

  2009cited by this paper
• Dietary sources of lignans and isoflavones modulate responses to estradiol in estrogen reporter mice.

  2009cited by this paper
• Prognostic and predictive factors.

  2009cited by this paper
• Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats

  2009cited by this paper
• RANK/RANKL: Regulators of Immune Responses and Bone Physiology

  2008cited by this paper
• Docosahexaenoic Acid and 17β-Estradiol Co-Treatment Is More Effective Than 17β-Estradiol Alone in Maintaining Bone Post-Ovariectomy

  2008cited by this paper
• Ovariectomy-induced hyperphagia does not modulate bone mineral density or bone strength in rats.

  2008cited by this paper
• Ovariectomy in the rat induces a rapid increase in the urinary excretion of hydroxylysine glycosides and non-reducible crosslink residues

  2007cited by this paper
• Short- to mid-term effects of ovariectomy on bone turnover, bone mass and bone strength in rats.

  2007influential reference
• Effects of dietary supplementation with flax during prepuberty on fatty acid profile, mammogenesis, and bone resorption in gilts.

  2007cited by this paper
• Endogenous Estrogen Levels and the Effects of Ultra‐Low‐Dose Transdermal Estradiol Therapy on Bone Turnover and BMD in Postmenopausal Women

  2007cited by this paper
• Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions.

  2007cited by this paper
• Flaxseed Alone or in Combination with Tamoxifen Inhibits MCF-7 Breast Tumor Growth in Ovariectomized Athymic Mice with High Circulating Levels of Estrogen

  2007cited by this paper
• An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans

  2007cited by this paper
• Biology of RANK, RANKL, and osteoprotegerin

  2007cited by this paper
• Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator.

  2007cited by this paper
• Effects of garlic oil on postmenopausal osteoporosis using ovariectomized rats: comparison with the effects of lovastatin and 17β‐estradiol

  2006cited by this paper
• Natural health product use in Canada: analysis of the National Population Health Survey.

  2006cited by this paper
• The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial.

  2005cited by this paper
• Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer

  2005cited by this paper
• Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice.

  2005cited by this paper
• Prognostic and predictive factors.

  2004cited by this paper
• Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route.

  2004cited by this paper
• National use of postmenopausal hormone therapy: annual trends and response to recent evidence.

  2004cited by this paper
• Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy.

  2004cited by this paper
• Botanical dietary supplement use in peri- and postmenopausal women

  2003cited by this paper
• Effects of Estradiol and Progesterone on Vertebral Collagen, Glycosaminoglycans and Phosphatases in Ovariectomized Adult Rats

  2003cited by this paper
• Flaxseed Improves Lipid Profile without Altering Biomarkers of Bone Metabolism in Postmenopausal Women

  2002influential reference
• The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.

  2002cited by this paper
• Safety of Botanical Dietary Supplements

  2002cited by this paper
• Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women.

  2002cited by this paper
• Exposure to Flaxseed and its Purified Lignan Reduces Bone Strength in Young but Not Older Male Rats

  2001cited by this paper
• Minireview: the OPG/RANKL/RANK system.

  2001cited by this paper
• Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats

  2001cited by this paper
• Osteoporosis prevention, diagnosis, and therapy.

  2001cited by this paper
• Metabolism and functions of highly unsaturated fatty acids: An update

  2001cited by this paper
• Nutritional and hematological impact of dietary flaxseed and defatted flaxseed meal in rats.

  2000cited by this paper
• Molecular Markers of Bone Turnover: Biochemical, Technical and Analytical Aspects

  2000influential reference
• Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat.

  1999cited by this paper
• Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.

  1999cited by this paper
• Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells.

  1998cited by this paper
• Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

  1998cited by this paper
• Components of the AIN-93 diets as improvements in the AIN-76A diet.

  1997influential reference
• FDA Guidelines and animal models for osteoporosis.

  1995cited by this paper
• Guide to the care and use of experimental animals

  1993cited by this paper
• Temporal relationship between bone loss and increased bone turnover in ovariectomized rats

  1988influential reference
• Metabolism and function

  1950cited by this paper

• Physiological and Pathological Considerations for the Use of Flaxseed as a Therapeutic Dietary Strategy

  2023cites this paper
• A COMPREHENSIVE REVIEW ON RECENT NOVEL FOOD AND INDUSTRIAL APPLICATIONS OF FLAXSEED: 2014 ONWARDS

  2022cites this paper
• Phytochemicals affect T helper 17 and T regulatory cells and gut integrity: implications on the gut-bone axis.

  2020cites this paper
• Bioaccessibility and bioavailability of calcium in sprouted brown and golden flaxseed.

  2020cites this paper
• Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets

  2019cites this paper
• Synergistic attenuation of ovariectomy-induced bone loss by combined use of fish oil and 17β-oestradiol

  2017cites this paper
• Lifelong intake of flaxseed or menhaden oil to provide varying n-6 to n-3 PUFA ratios modulate bone microarchitecture during growth, but not after OVX in Sprague-Dawley rats.

  2017cites this paper
• Flaxseed secoisolariciresinol diglucoside (SDG) during lactation improves bone metabolism in offspring at adulthood

  2017cites this paper
• Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases

  2016cites this paper
• Effect of Aqueous Extract of Defatted Flaxseeds ( Linum Usitatissimum Linn ) on Fructose-Induced Hypertension in Rats by Inhibiting Angiotensin-Converting Enzyme ( ACE )

  2016cites this paper
• The Role of Functional Foods and Their Bioactive Components in Bone Health

  2015cites this paper
• An 8-O-4' norlignan exerts oestrogen-like actions in osteoblastic cells via rapid nongenomic ER signaling pathway.

  2015cites this paper
• Nutrition, Exercise and Epigenetics: Ageing Interventions

  2015cites this paper